| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $673K | -26.1% |
| SG&A Expense | $660K | -59.7% |
| Operating Income | -$1.3M | +47.7% |
| Net Income | -$1.8M | +54.0% |
| EPS (Basic) | -$0.36 | +64.0% |
| EPS (Diluted) | -$0.36 | +64.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $810K | -6.5% |
| Current Assets | $901K | -6.4% |
| Total Assets | $1.1M | +13.3% |
| Current Liabilities | $3.7M | +10.8% |
| Long-term Debt | $29K | +0.0% |
| Stockholders' Equity | -$2.8M | -14.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$986K | +28.2% |
| Capital Expenditures | $206K | +2842.9% |
| Investing Cash Flow | -$192K | -611.1% |
| Financing Cash Flow | $1.1M | -39.5% |
| Free Cash Flow | -$1.2M | +13.7% |